Watch Ticker

Tempest Therapeutics, Inc. Common Stock

Go to Tempest Therapeutics, Inc. Common Stock Website

$7.39

-0.07 (-0.94%)

Live

Previous Close

$7.46

Day Range

$7.22 - $7.46

Previous Day Range

$7.2601 - $7.54

Market Cap

$27.6 million USD

Day Vol.

28172

Previous Day Vol.

35533

Currency

USD

Primary Exchange

Nasdaq

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic pr...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Tempest Therapeutics, a clinical-stage biotechnology company, announced that it has granted nonqualified stock options to one employee under its 2023 Inducement Plan. The stock options will vest over a four-year period.

Related tickers: TPST.

Read Full Article

N/A - Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma (HCC)

Tempest Therapeutics received Orphan Drug Designation from the FDA for its drug amezalpat to treat hepatocellular carcinoma, a type of liver cancer. The drug showed promising results in a Phase 1b/2 clinical study, improving overall survival and response rates compared to the standard of care.

Related tickers: TPST.

Read Full Article

Trending Tickers

Please sign in to view